Transcode Therapeutics, Inc. (RNAZ): Total Assets
$162.40M
As of 2025-12-31
$151.01M
As of 2026-06-30
+177.6%
3-year compound annual growth
n/m
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $162.40M | n/m | 2026-04-15, Balance as of period end |
| 2024-12-31 | $7.29M | +41.1% | 2026-04-15, Balance as of period end |
| 2023-12-31 | $5.17M | -31.9% | 2025-04-15, Balance as of period end |
| 2022-12-31 | $7.59M | -66.9% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $22.94M | n/m | 2023-03-31, Balance as of period end |
| 2020-12-31 | $1.06M | n/a | 2022-03-31, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | 2025-12-31 | $162.40M | n/m |
| Cypherpunk Technologies Inc. (CYPH) | 2025-12-31 | $163.18M | +232.2% |
| Apimeds Pharmaceuticals US, Inc. (APUS) | 2025-12-31 | $164.18M | n/m |
| Aclaris Therapeutics, Inc. (ACRS) | 2025-12-31 | $160.46M | -27.2% |
| Aquestive Therapeutics, Inc. (AQST) | 2025-12-31 | $160.43M | +58.2% |
| Gyre Therapeutics, Inc. (GYRE) | 2025-12-31 | $166.13M | +32.5% |
| Climb Bio, Inc. (CLYM) | 2025-12-31 | $167.74M | -22.8% |
| Boundless Bio, Inc. (BOLD) | 2025-12-31 | $157.06M | -23.9% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | 2025-12-31 | $168.19M | +7.9% |
Compare RNAZ, CYPH, APUS, ACRS side by side · Screen every company in Pharmaceutical Preparations ↗